Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Featured Clinical Focus
AMLBiomarker-Driven Lung CancerBone Marrow & SCTBTK Inhibitors: In-FocusCAR T-Cell TherapyChronic Lymphocytic LeukemiaEGFR-Positive Lung CancerEndometrial CancerFollicular LymphomaHCCLung CancerMantle Cell LymphomaMPNsMultiple MyelomaRenal Cell CarcinomaSmall Cell Lung CancerThyroid Cancers
Clinical Focus
View MoreBrain CancerBreast CancerGastrointestinal CancerGenitourinary CancersGynecologic CancersHead & Neck CancersHematologyLeukemiasLung CancerLymphomasMelanomaSarcomaSkin CancersThyroid Cancers
Spotlight
View MoreCase Based Peer PerspectivesCase-Based Roundtable SeriesClinical TrialsPodcastsPrecision MedicineSpecial Reports
NEWS
All NewsClinical FocusSpecial Reports
CONFERENCES
Conference CoverageConference Listing
MEDIA
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPodcastsPrecision Medicine
PUBLICATIONS
All PublicationsEvolving ParadigmsRoundtable Meetings SpotlightTargeted Therapies in Oncology
CME/CE
RESOURCES
Case-Based Roundtable SeriesClinical TrialsPartnersPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
eNewsletter
  • About Us
  • Advertise
  • Contact Us
  • CureToday.com
  • CancerNetwork.com
  • OncLive.com
  • OncNursingNews.com
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Advertisement
Featured Clinical Focus
  • AML
  • Biomarker-Driven Lung Cancer
  • Bone Marrow & SCT
  • BTK Inhibitors: In-Focus
  • CAR T-Cell Therapy
  • Chronic Lymphocytic Leukemia
  • EGFR-Positive Lung Cancer
  • Endometrial Cancer
  • Follicular Lymphoma
  • HCC
  • Lung Cancer
  • Mantle Cell Lymphoma
  • MPNs
  • Multiple Myeloma
  • Renal Cell Carcinoma
  • Small Cell Lung Cancer
  • Thyroid Cancers
Clinical FocusSee All >
  • Brain Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Cancers
  • Head & Neck Cancers
  • Hematology
  • Leukemias
  • Lung Cancer
  • Lymphomas
  • Melanoma
  • Sarcoma
  • Skin Cancers
  • Thyroid Cancers
SpotlightSee All >
  • Case Based Peer Perspectives
  • Case-Based Roundtable Series
  • Clinical Trials
  • Podcasts
  • Precision Medicine
  • Special Reports
baltimore conference logo
  • About Us
  • Advertise
  • Contact Us
  • CureToday.com
  • CancerNetwork.com
  • OncLive.com
  • OncNursingNews.com
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

A 73-Year-Old Male With Mantle Cell Lymphoma

Brian Hill, MD, reviews the case of a 73-year-old man with mantle cell lymphoma and discusses the latest data and treatment approaches.

EP. 1: 73-Year-Old Man With Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews the case of a 73-year-old man with mantle cell lymphoma.

EP. 2: Frontline Treatment Options in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews frontline treatment options for patients with mantle cell lymphoma.

EP. 3: Second-Line Treatment Options in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews second-line treatment options for patients with relapsed/refractory mantle cell lymphoma.

EP. 4: Results of the ZUMA-2 Trial in Relapsed/Refractory Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews practice-changing data from the ZUMA-2 trial in patients with relapsed/refractory mantle cell lymphoma.

EP. 5: Mitigating CAR T–Related Toxicities in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews strategies for mitigating toxicities associated with CAR T-cell therapy.

EP. 6: Role of CAR T-cell Therapy in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews the role of CAR T-cell therapy in mantle cell lymphoma.

EP. 7: Unmet Needs and Future Directions in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews unmet needs and future directions in the management of mantle cell lymphoma.

Advertisement
Advertisement